CIA Professor David Whiteman

CIA Professor David Whiteman, QIMR Berghofer Medical Research Institute

CIA Whiteman has research interests in the causes, prevention and treatment of cancer. He is currently lead investigator of PROBE-NET NHMRC CRE Grant 2013-2017) and co-principal investigator of the BEAGESS genome-wide association study with Dr Tom Vaughan (US NIH R01 2009-11). Previously, he was lead investigator on two multicentre, population-based studies of oesophageal cancer (NHMRC program 2002-6) and BO (US NIH R01 2002-7) that were forerunners to PROBE-NET. He is a member of the Steering Committee of BEACON, Chair of the Barrett’s Guidelines Committee for the Cancer Council Australia, and the Advisory Group to the Medical Services Advisory Committee. He serves on the editorial boards of Cancer Epidemiology, BMC Gastroenterology and Frontiers of Cancer Epidemiology Prevention.